How to Launch a Patient Support Program (PSP) in Just 3 Weeks!

For pharma companies, launching a new therapy is only part of the journey. Ensuring patients start and stay on treatment often depends on having the right support in place from day one. Yet building a digital patient support program (PSP) from scratch can take months, delaying impact, limiting reach, and leaving patients without the tools they need.

The MyTherapy platform changes that. Developed over more than a decade and trusted by millions of patients worldwide, it allows pharma to configure, brand, and deploy a compliant, treatment-specific PSP in as little as 3 weeks, so patients get timely, tailored support, and companies can deliver measurable outcomes faster.

Why Speed Matters in Digital Health  

Digital patient support programs improve adherence, persistence, and patient outcomes, but their impact depends on reaching patients quickly. In fast-moving healthcare markets, every week counts.  

With more than a decade of refinement, the MyTherapy platform has been built to address the everyday needs of people taking regular medications. It already serves over 12 million patients globally, across every major therapeutic area. This proven infrastructure makes it possible to launch tailored PSPs for specific treatments in just 3 weeks.

The MyTherapy Platform: Ready-to-Use Patient Support

MyTherapy is a free app for iOS and Android, available in 30+ languages and shaped by years of patient feedback and clinical testing.

Core features include:

• Medication reminders
• Inventory tracking & refill alerts
• Symptom tracking
• Activity reminders
• Care team integration
• Appointment management
• PDF health reports
• Drug interaction checker (selected markets)
• Integration with online pharmacies (selected markets)

These capabilities handle complex, real-world medication routines and have been shown to improve self-reported adherence using the validated MARS-5 questionnaire.

Configurable Modules Based on Patient Needs  

Some patients require additional, therapy-specific support. For these cases, smartpatient works with partners to create custom PSP configurations within MyTherapy, accessible only to the defined patient group.

Modules can include:

• Automated regimen & titration scheduling

• Gamification and Badges

• Onboarding support

• Connectivity to other patient support channels

• Development and integration of SaMD modules according to ISO13485 standards
• Injection site tracking

• Custom educational content

Modules can be configured per market, and new features can be developed in parallel to launch for later updates, avoiding delays.

The 3-Week PSP Journey to Launch  

Week 1: Gathering requirements & setting up the program

Define therapy needs, select core features, and identify any configurable modules to ensure the PSP is tailored and compliant.

Configure the PSP on the MyTherapy platform, including branding and a custom setup assistant, plus any therapy-specific modules like titration or injection site tracking.

Week 2: Final alignment and approvals

Run tests and secure medical, legal, and regulatory approvals so the program is fully ready for patients.

Week 3: Acceptance testing and launch

Validate performance with user testing, then roll out the PSP to patients—live in just 3 weeks.

From MVP to Continuous Growth

Our approach is to launch a Minimum Viable Product, a fully functional, compliant PSP that can evolve based on real-world patient feedback.

Post-launch, we focus on:
• Onboarding existing MyTherapy users
• Running targeted adoption campaigns and HCP outreach
• Reviewing program performance with a Partner Success Manager
• Scaling to new markets or adding advanced functionality over time